|
|
|
|
|
16.06.26 - 12:45
|
Canopy Growth-Aktie: Alles nur noch Rauch? (Sharedeals)
|
|
|
Die Canopy Growth-Aktie setzte auch zum Wochenbeginn ihre leichte Talfahrt fort und fiel am gestrigen Montag unter die so wichtige Kursmarke von 1 US$. Können die Quartalszahlen dem kanadischen Cannabisproduzenten denn keinen Rückenwind geben? Zu geringe Verbesserungen Die Zahlen für das vierte Geschäftsquartal und das gesamte Geschäftsjahr 2025/26 zeigen ein altbekanntes Bild bei Canopy Growth: […]
The post Canopy Growth-Aktie: Alles nur noch Rauch? first appeared on sharedeals.de....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.06.26 - 13:06
|
Canopy Growth Reports Fourth Quarter and Fiscal Year 2026 Financial Results; Delivers Q4 FY2026 Net Revenue Growth of 27% in Canada Medical and 68% in International Markets Cannabis (Business Wire)
|
|
|
Full-year 2026 growth driven by net revenue increases of 20% in Canada adult-use cannabis and 18% in Canada medical
Completed acquisition of MTL Cannabis, positioning Canopy Growth as Canada's leading medical cannabis company by revenue
Ended the fiscal year with $131.3M of net cash following strategic recapitalization completed in January 2026
Strategic decisions and financial discipline in FY2026 establish a foundation for acceleration and growthSMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today announced its financial results for the three months ended March 31, 2026 ("Q4 FY2026") and the fiscal year ended March 31, 2026 ("FY2026"). All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.
“In fiscal 2026, we reset the business, laid a disciplined foundation, and made deliberate investments, including acquiring MTL Cannabis, that...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|